Picture of Alligator Bioscience AB logo

ATORX Alligator Bioscience AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Alligator Bioscience Announces Optimize-1 Trial Update; Cohort Fully Dosed With No Adverse Effects Reported

Jan 18 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * ALLIGATOR BIOSCIENCE ANNOUNCES OPTIMIZE-1 TRIAL UPDATE:
COHORT
FULLY DOSED WITH NO ADVERSE EFFECTS REPORTED

Source text for Eikon:  ID:nPn4dyljxa 
Further company coverage:  ATORX.ST 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Alligator Bioscience AB

See all news